India to Myanmar: Spironolactone Export Trade Route

The India to Myanmar Spironolactone corridor is one of India's established pharmaceutical export routes, with 23 shipments documented worth a combined $533.7K USD. The route is dominated by ARAVIS PHARMACEUTICALS, which alone accounts for roughly 74% of all export value, reflecting the consolidated nature of India's spironolactone manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $23.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 19.6%, placing it at rank #3 among India's top spironolactone export destinations globally.

On the import side, key buyers of Indian spironolactone in Myanmar include MONDAY FAMILY PTE LTD, WIN WIN EXP IMP CO LTD,U LUN STREET, WIN WIN EXP IMP CO LIMITED and 11 others. MONDAY FAMILY PTE LTD is the single largest importer with 2 shipments valued at $174.1K USD.

India's spironolactone exports to Myanmar are driven primarily by a handful of large-scale manufacturers. ARAVIS PHARMACEUTICALS with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Myanmar benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ARAVIS PHARMACEUTICALS, SIVARA PHARMACEUTICALS, LIVEALTH BIOPHARMA PRIVATE LIMITED — together account for 95% of total trade value on this route. The average shipment value of $23.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as belactone tablets,spironolactone,bp 25 mg excipients q.s. batch no.b41-84 to b4189, mfg.dt.03/2024,exp.dt.05/2026 and formulation tablets belactone tablets 25 mgspironolactone bp 25 mg excipientsq.s. 30x10, suggesting that buyers in Myanmar tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MONDAY FAMILY PTE LTD is the largest importer with 2 shipments worth $174.1K USD — representing 33% of all spironolactone imports from India on this route. A total of 14 buyers are active on this corridor.